Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive Esophagitis

NCT07746518 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Healed Erosive Esophagitis

Interventions

DRUG: DWP14012 20mg
DRUG: DWP14012 20 mg placebo
DRUG: DWC202517 15 mg
DRUG: DWC202517 15 mg placebo

Sponsor

Daewoong Pharmaceutical Co. LTD.